| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/23/2008 | EP1912997A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912996A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912995A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912989A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 04/23/2008 | EP1912921A2 Tetraazaporphyrin-based compounds and their uses |
| 04/23/2008 | EP1912653A2 Heterocyclic benzodiazepine cgrp receptor antagonists |
| 04/23/2008 | EP1716150B1 Substituted heterocyclic compounds and methods of use |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | CN101166743A Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha] imidazole-3-sulfonic acid |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN100383145C 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 04/23/2008 | CN100383142C Process for preparation of imipenem |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361659 7-Difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (2-chloro-5-sulfamoyl-thiophen-3-yl)-amide; metabotropic glutamate receptors antagonist; anxiolitic, analgesic, hyperglycemic agent; absorption, advantages in pharmacokinetics in distribution transport to the brain |
| 04/22/2008 | US7361656 Prenyl transferase inhibitors |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008045268A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045267A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045266A2 Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor |
| 04/17/2008 | WO2008044127A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | WO2008043800A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 04/17/2008 | WO2008043799A1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
| 04/17/2008 | WO2008043745A1 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 04/17/2008 | WO2008020455A3 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 04/17/2008 | WO2008008887A3 Gpr119 agonists for treating metabolic disorders |
| 04/17/2008 | WO2007139992A3 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS |
| 04/17/2008 | US20080091013 Tritium-Traced Saxitoxin Dihydrochloride and Method for the Production Thereof |
| 04/17/2008 | US20080090978 Ligand of cyclopentadiene fused to heterocycle with atom(s) of boron, nitrogen, oxygen, aluminum, silicon, phosphorus, sulfur, gallium, germanium, arsenic, selenium, indium, tin, antimony and/or tellurium; coordination catalysts; isotatic, syndiotactic or atactic polyethylene, polypropylene or copolymer |
| 04/17/2008 | US20080090892 Amorphous asenapine and processes for preparing same |
| 04/17/2008 | US20080090852 Bicyclic Heteroaromatic Compounds |
| 04/17/2008 | US20080090851 Bicyclic Heteroaromatic Compounds |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090831 Cytotoxic agents |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090253 Membrane-Based Lateral Flow Assay Devices that Utilize Phosphorescent Detection |
| 04/17/2008 | US20080090103 Hematin catalyst deposited on an electrically charged substrate in layers alternating with a polyelectrolyte, catalyst derivatized with non-proteinaceous amphipathic groups; a mimic of horseradish peroxidase in polymerizing aromatic monomers |
| 04/17/2008 | US20080089896 Bivalent SMAC mimetics and the uses thereof |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666653A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 04/17/2008 | CA2666373A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | CA2665127A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | CA2664900A1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1910383A1 Benzodiazepine derivatives and uses thereof in medical field |
| 04/16/2008 | EP1910374A1 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels |
| 04/16/2008 | EP1910373A1 Fungicide 6-phenyl-triazolopyrimidinyl amines |
| 04/16/2008 | EP1910372A1 Fungicidal 5-alkyl-6-phenylpyrazolopyrimidin-7-ylamines |
| 04/16/2008 | EP1910371A1 Fungicidal 5-methyl-6-phenylpyrazolopyrimidin-7-ylamines |
| 04/16/2008 | EP1910370A1 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| 04/16/2008 | EP1910369A1 Fused heterocycles as lck inhibitors |
| 04/16/2008 | EP1910368A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 04/16/2008 | EP1910367A2 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1909580A1 Fungicide 5-methyl-6-phenyl-triazolopyrimidinyl amines |
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101163404A Use of 5-alkyl-6-phenylalkyl-7-amino-azolopyrimidines, novel azolopyrimidines, methods for the production thereof, and agents containing the same |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381444C Silicon phthalocyanine compound and composite, their preparation and application thereof |
| 04/16/2008 | CN100381443C Prepn process of imide derivative |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358327 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358250 Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7358242 N-benzyl-2-[4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-N-isopropyl-acetamide; cholecystokinin-A (CCK-A) receptor agonist; antidiabetic; obesity |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | US7358238 3-(2-Phenoxymethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]azepin-9-one; inhibiting the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1); increase intracellular concentration of active glucocorticoid; metabolic disorders, insulin resistance, dyslipidemia, obesity |
| 04/15/2008 | CA2320304C Fungicidal 7-alkyl-triazolopyrimidines |
| 04/15/2008 | CA2170379C Photosensitizers |
| 04/10/2008 | WO2008041264A1 Isoindolo-quinoxaline derivatives having antitumor activity, process for their production and their use |
| 04/10/2008 | WO2008041090A1 Malanin concentrating hormone receptor-1 antagonist pyridinones |
| 04/10/2008 | WO2008040995A1 Indazoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040974A1 Indoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040951A1 Compounds |
| 04/10/2008 | WO2008040332A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 04/10/2008 | WO2008021411A3 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
| 04/10/2008 | WO2008021410A3 Highly pure pemetrexed diacid and processes for the preparation thereof |
| 04/10/2008 | WO2008002959A3 Hiv integrase inhibitors |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007137785A3 Process useful in the preparation of morphinan antagonists |
| 04/10/2008 | WO2007015280A8 Benzodiazepine derivatives and uses thereof in medical field |
| 04/10/2008 | WO2007003525A3 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors |
| 04/10/2008 | US20080085907 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines |
| 04/10/2008 | US20080085898 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
| 04/10/2008 | US20080085889 Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them |